Molecular design of the γδT cell receptor ectodomain encodes biologically fit ligand recognition in the absence of mechanosensing.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
29 06 2021
Historique:
entrez: 26 6 2021
pubmed: 27 6 2021
medline: 15 12 2021
Statut: ppublish

Résumé

High-acuity αβT cell receptor (TCR) recognition of peptides bound to major histocompatibility complex molecules (pMHCs) requires mechanosensing, a process whereby piconewton (pN) bioforces exert physical load on αβTCR-pMHC bonds to dynamically alter their lifetimes and foster digital sensitivity cellular signaling. While mechanotransduction is operative for both αβTCRs and pre-TCRs within the αβT lineage, its role in γδT cells is unknown. Here, we show that the human DP10.7 γδTCR specific for the sulfoglycolipid sulfatide bound to CD1d only sustains a significant load and undergoes force-induced structural transitions when the binding interface-distal γδ constant domain (C) module is replaced with that of αβ. The chimeric γδ-αβTCR also signals more robustly than does the wild-type (WT) γδTCR, as revealed by RNA-sequencing (RNA-seq) analysis of TCR-transduced

Identifiants

pubmed: 34172580
pii: 2023050118
doi: 10.1073/pnas.2023050118
pmc: PMC8256041
pii:
doi:

Substances chimiques

Ligands 0
Receptors, Antigen, T-Cell, alpha-beta 0
Receptors, Antigen, T-Cell, gamma-delta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI143565
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI073922
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI115698
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136301
Pays : United States

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Immunol Rev. 2012 Nov;250(1):102-19
pubmed: 23046125
EMBO J. 1998 Jan 2;17(1):10-26
pubmed: 9427737
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8373-8
pubmed: 26056289
Curr Top Microbiol Immunol. 2007;314:113-41
pubmed: 17593659
Cell Immunol. 2015 Jul;296(1):87-94
pubmed: 25958271
Nat Immunol. 2019 Feb;20(2):121-128
pubmed: 30664765
Cell. 2018 Jul 26;174(3):672-687.e27
pubmed: 30053426
Immunol Rev. 2015 Sep;267(1):30-55
pubmed: 26284470
Immunity. 2018 Nov 20;49(5):857-872.e5
pubmed: 30413363
Elife. 2017 Nov 07;6:
pubmed: 29111975
J Comput Chem. 2014 Feb 15;35(5):406-13
pubmed: 24302199
J Immunol. 1985 Aug;135(2):1281-7
pubmed: 2409144
Cell. 2014 Apr 10;157(2):357-368
pubmed: 24725404
Science. 1994 Apr 8;264(5156):267-70
pubmed: 8146660
J Leukoc Biol. 2020 Jun;107(6):1045-1055
pubmed: 31994778
J Immunol. 2013 Mar 1;190(5):1982-90
pubmed: 23338239
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
J Immunol. 2010 Jun 1;184(11):5959-63
pubmed: 20435924
Immunity. 2016 Jan 19;44(1):194-206
pubmed: 26795250
Nat Immunol. 2008 Jul;9(7):777-84
pubmed: 18516039
Nat Commun. 2017 Dec 4;8(1):1911
pubmed: 29203769
Pharmacol Rev. 2005 Dec;57(4):397-409
pubmed: 16382098
J Exp Med. 1994 Aug 1;180(2):673-9
pubmed: 8046340
Immunity. 2005 Jan;22(1):71-80
pubmed: 15664160
Science. 2005 Apr 8;308(5719):227-31
pubmed: 15821084
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Nat Immunol. 2012 Sep;13(9):872-9
pubmed: 22885985
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5658-63
pubmed: 24706811
Genome Biol. 2014;15(12):550
pubmed: 25516281
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):622-7
pubmed: 9892683
PLoS One. 2011 May 10;6(5):e19680
pubmed: 21572959
J Biol Chem. 2016 Dec 2;291(49):25292-25305
pubmed: 27707880
Nat Immunol. 2013 Nov;14(11):1137-45
pubmed: 24076636
J Immunol. 1989 Aug 15;143(4):1123-8
pubmed: 2501389
Immunity. 2018 Nov 20;49(5):829-841.e6
pubmed: 30389415
Cell Rep. 2014 Jun 12;7(5):1704-1715
pubmed: 24857663
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5928-32
pubmed: 2788280
Front Immunol. 2018 Apr 27;9:929
pubmed: 29755480
J Biol Chem. 2009 Nov 6;284(45):31028-37
pubmed: 19755427
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8204-E8213
pubmed: 28811364
J Biol Chem. 2018 Oct 12;293(41):15991-16005
pubmed: 30135211
J Comput Chem. 2009 Jul 30;30(10):1545-614
pubmed: 19444816
J Biol Chem. 2006 Dec 29;281(52):40369-78
pubmed: 17071611
Cancer Res. 2006 Sep 1;66(17):8878-86
pubmed: 16951205
Expert Opin Biol Ther. 2005 May;5(5):627-38
pubmed: 15934839
Eur J Immunol. 2003 Feb;33(2):368-80
pubmed: 12645934
Proc Natl Acad Sci U S A. 1985 Dec;82(23):8158-62
pubmed: 3934668
J Exp Med. 1997 Feb 17;185(4):731-44
pubmed: 9034151
J Immunol. 2010 Jul 15;185(2):867-76
pubmed: 20548034
J Exp Med. 2002 Jun 3;195(11):1419-31
pubmed: 12045240
Immunity. 2002 Jun;16(6):827-38
pubmed: 12121664
J Immunol. 2006 Jun 1;176(11):6812-23
pubmed: 16709841
Nat Rev Immunol. 2017 Dec;17(12):733-745
pubmed: 28920588
Curr Opin Immunol. 2010 Apr;22(2):185-92
pubmed: 20074925
Annu Rev Immunol. 2013;31:443-73
pubmed: 23298205
Ann N Y Acad Sci. 1995 Sep 29;764:47-9
pubmed: 7486568
Biophys J. 2011 Oct 19;101(8):2026-36
pubmed: 22004757
Immunity. 2013 Dec 12;39(6):1032-42
pubmed: 24239091
Front Immunol. 2015 Sep 03;6:441
pubmed: 26388869
Nat Rev Immunol. 2016 Feb;16(2):102-11
pubmed: 26781939
Nat Immunol. 2003 Jul;4(7):657-63
pubmed: 12796775
Immunity. 2012 Sep 21;37(3):524-34
pubmed: 22960222
Mol Biol Cell. 2015 Feb 15;26(4):685-95
pubmed: 25518938
Sci Immunol. 2018 Dec 14;3(30):
pubmed: 30552102
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21336-21345
pubmed: 32796106
Biophys J. 2017 Jul 11;113(1):120-131
pubmed: 28700910
Nat Immunol. 2012 Apr 01;13(5):511-8
pubmed: 22473038
Immunity. 2002 Oct;17(4):487-99
pubmed: 12387742
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Trends Immunol. 2018 Aug;39(8):596-609
pubmed: 30060805
Proc Natl Acad Sci U S A. 2016 May 17;113(20):5610-5
pubmed: 27140637
Immunity. 2005 May;22(5):595-606
pubmed: 15894277
Cell Rep. 2017 Jun 20;19(12):2469-2476
pubmed: 28636936
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
J Immunol. 2014 Mar 1;192(5):2210-8
pubmed: 24489104
J Immunol. 1984 Dec;133(6):3188-94
pubmed: 6436376
Cell. 1994 Jan 14;76(1):29-37
pubmed: 8287478
J Biol Chem. 1996 Dec 27;271(52):33639-46
pubmed: 8969233
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11875-9
pubmed: 8265641
J Immunol. 2010 Sep 1;185(5):2951-9
pubmed: 20660709
Trends Immunol. 2017 Feb;38(2):116-127
pubmed: 27986392
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1889-1894
pubmed: 29432160
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1517-22
pubmed: 25605925
J Immunol. 2014 Sep 1;193(5):2587-99
pubmed: 25070852
Mol Cell. 2019 Mar 7;73(5):1015-1027.e7
pubmed: 30711376
Eur J Immunol. 2012 Sep;42(9):2505-10
pubmed: 22829134
Nucleic Acids Res. 2008 Apr;36(7):2295-300
pubmed: 18287115
J Exp Med. 2000 Mar 20;191(6):937-48
pubmed: 10727456
Annu Rev Biophys. 2008;37:399-416
pubmed: 18573088

Auteurs

Robert J Mallis (RJ)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Department of Dermatology, Harvard Medical School, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Jonathan S Duke-Cohan (JS)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Dibyendu Kumar Das (DK)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235.

Aoi Akitsu (A)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Adrienne M Luoma (AM)

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637.

Debasis Banik (D)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235.

Hannah M Stephens (HM)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235.

Paul W Tetteh (PW)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Caitlin D Castro (CD)

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637.

Sophie Krahnke (S)

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637.

Rebecca E Hussey (RE)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.

Brian Lawney (B)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115.

Kristine N Brazin (KN)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Pedro A Reche (PA)

Department of Immunology, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Wonmuk Hwang (W)

Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843; hwm@tamu.edu ejadams@uchicago.edu matt.lang@vanderbilt.edu ellis_reinherz@dfci.harvard.edu.
Department of Materials Science and Engineering, Texas A&M University, College Station, TX 77843.
Department of Physics and Astronomy, Texas A&M University, College Station, TX 77843.
School of Computational Sciences, Korea Institute for Advanced Study, 02455 Seoul, Korea.

Erin J Adams (EJ)

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637; hwm@tamu.edu ejadams@uchicago.edu matt.lang@vanderbilt.edu ellis_reinherz@dfci.harvard.edu.

Matthew J Lang (MJ)

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235; hwm@tamu.edu ejadams@uchicago.edu matt.lang@vanderbilt.edu ellis_reinherz@dfci.harvard.edu.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235.

Ellis L Reinherz (EL)

Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115; hwm@tamu.edu ejadams@uchicago.edu matt.lang@vanderbilt.edu ellis_reinherz@dfci.harvard.edu.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Department of Medicine, Harvard Medical School, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH